Literature DB >> 14295514

NEW RESEARCH ON INFLUENZA: STUDIES WITH NORMAL VOLUNTEERS. COMBINED CLINICAL STAFF CONFERENCE AT THE NATIONAL INSTITUTES OF HEALTH.

V KNIGHT, J A KASEL, R H ALFORD, F LODA, J A MORRIS, F M DAVENPORT, R Q ROBINSON, E L BUESCHER.   

Abstract

Keywords:  ANTIBODY FORMATION; ANTIGEN-ANTIBODY REACTIONS; CLINICAL RESEARCH; IMMUNOLOGY; INFLUENZA; INFLUENZA VACCINE; INFLUENZA VIRUSES; VACCINATION; VIRULENCE

Mesh：

Substances：

Year:  1965        PMID： 14295514     DOI： 10.7326/0003-4819-62-6-1307

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

1.  Potential complications of influenza A infections.

Authors:  S R Jones
Journal:  West J Med       Date:  1976-11

Review 2.  Minimum Infective Dose of the Major Human Respiratory and Enteric Viruses Transmitted Through Food and the Environment.

Authors:  Saber Yezli; Jonathan A Otter
Journal:  Food Environ Virol       Date:  2011-03-16       Impact factor: 2.778

Review 3.  The human side of influenza.

Authors:  Christine M Oshansky; Paul G Thomas
Journal:  J Leukoc Biol       Date:  2012-02-23       Impact factor: 4.962

4.  Clinical prediction rules combining signs, symptoms and epidemiological context to distinguish influenza from influenza-like illnesses in primary care: a cross sectional study.

Authors:  Barbara Michiels; Isabelle Thomas; Paul Van Royen; Samuel Coenen
Journal:  BMC Fam Pract       Date:  2011-02-09       Impact factor: 2.497

5.  Influenza virus in human exhaled breath: an observational study.

Authors:  Patricia Fabian; James J McDevitt; Wesley H DeHaan; Rita O P Fung; Benjamin J Cowling; Kwok Hung Chan; Gabriel M Leung; Donald K Milton
Journal:  PLoS One       Date:  2008-07-16       Impact factor: 3.240

6.  Quantitative aerobiologic analysis of an influenza human challenge-transmission trial.

Authors:  Paul Jacob Bueno de Mesquita; Catherine J Noakes; Donald K Milton
Journal:  Indoor Air       Date:  2020-06-15       Impact factor: 5.770
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.